Atyr Pharma Inc (NASDAQ:ATYR) shares, rose in value on Thursday, March 27, with the stock price up by 0.62% to the previous day’s close as strong demand from buyers drove the stock to $3.26.
Actively observing the price movement in the last trading, the stock closed the session at $3.24, falling within a range of $3.21 and $3.34. The value of beta (5-year monthly) was 0.989. Referring to stock’s 52-week performance, its high was $4.66, and the low was $1.42. On the whole, ATYR has fluctuated by -15.76% over the past month.
With the market capitalization of Atyr Pharma Inc currently standing at about $289.68 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-12.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ATYR’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of ATYR currently trading nearly -7.45% and -10.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.47, while the 7-day volatility ratio is showing 6.59% which for the 30-day chart, stands at 10.32%. Furthermore, Atyr Pharma Inc (ATYR)’s beta value is 0.92, and its average true range (ATR) is 0.32.
A comparison of Atyr Pharma Inc (ATYR) with its peers suggests the former has fared considerably weaker in the market. ATYR showed an intraday change of 0.62% in last session, and over the past year, it grew by 69.79%%.
Data on historical trading for Atyr Pharma Inc (NASDAQ:ATYR) indicates that the trading volumes over the past 10 days have averaged 1.41 and over the past 3 months, they’ve averaged 1.29 million. According to company’s latest data on outstanding shares, there are 88.86 million shares outstanding.
Nearly 3.22% of Atyr Pharma Inc’s shares belong to company insiders and institutional investors own 62.69% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.92 million shares as on 2025-03-14, resulting in a short ratio of 3.39. According to the data, the short interest in Atyr Pharma Inc (ATYR) stood at 951.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 4.35 million. The stock has fallen by -9.94% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ATYR stock heading into the next quarter.
